liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Does co-location matter for formal knowledge collaboration in the Swedish biotechnology-pharmaceutical sector?
Linköping University, Faculty of Arts and Sciences. Linköping University, The Tema Institute, Technology and Social Change.
2003 (English)In: Research Policy, ISSN 0048-7333, E-ISSN 1873-7625, Vol. 32, no 3, 483-501 p.Article in journal (Refereed) Published
Abstract [en]

This article addresses the validity of assumptions about the importance of co-locality for innovation, by analyzing whether or not co-location matters for formal knowledge collaboration in the Swedish biotechnology-pharmaceutical sector, or biotech-pharma sector. The population of Swedish biotech-pharma firms has been defined, based on the three criteria of geographical location, their engagement in active knowledge development, and their specialized knowledge/product focus. The firms' patterns of regional, national and international collaboration with other firms and with universities is analyzed, as well as the differing collaborative patterns of small versus large firm. In addressing the theoretical questions about the relative importance of co-location for innovation, the article also provides an empirical overview of the Swedish biotech-pharma sector, especially trends over time. This paper thus contributes to the literature by expanding our empirical knowledge about one European biotech-pharma sectoral system, e.g. Sweden, as well as addressing the theoretical question about the relative importance of co-location for formal knowledge collaboration. ⌐ 2002 Elsevier Science B.V. All rights reserved.

Place, publisher, year, edition, pages
2003. Vol. 32, no 3, 483-501 p.
Keyword [en]
Biotechnology; Pharmaceuticals; Innovation systems; Sweden; Collaboration
National Category
Social Sciences Interdisciplinary
Identifiers
URN: urn:nbn:se:liu:diva-34020DOI: 10.1016/S0048-7333(02)00020-3Local ID: 20413OAI: oai:DiVA.org:liu-34020DiVA: diva2:254868
Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2017-12-13

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Alm, Håkan

Search in DiVA

By author/editor
Alm, Håkan
By organisation
Faculty of Arts and SciencesTechnology and Social Change
In the same journal
Research Policy
Social Sciences Interdisciplinary

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 57 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf